Healthcare Triangle is trading 5.01% down at $0.48 on October 9, 2026, with Nasdaq delisting appeal uncertainty as the company-specific overhang.
- The company was below Nasdaq’s $1.00 minimum bid-price requirement; October 8 was the appeal deadline. Its filing said it intended to request a hearing but did not confirm filing.
- Without an appeal, suspension was set for October 12. Nasdaq said reverse splits totaling 1-for-14,940 made it ineligible for standard compliance; a hearing request would stay suspension during panel review.